Abonneer je op onze nieuwsbrief om op de hoogte te blijven
Klik hier
  • BLS

Safety guide: Asbestos

BLS Safety Guide: Asbestos


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

In the five-year period 2016-2020, an average of about 1,500 workers per year were recognised as having an asbestos-related disease. In the same years, around 50% of workers who contracted asbestos-related diseases suffered a permanent impairment of no more than 25%, while 37% of technopaths died as a result of the occupational disease. Specifically in 2016, the proportion of workers with an impairment of no more than 25 per cent remained almost unchanged, but those with a fatal outcome rose to 43 per cent.

The use of asbestos was banned in Italy in 1992 with Law No. 257, which set the terms and procedures for the cessation of all activities involving the processing and extraction of this mineral. After this date, the only permitted work activities involving exposure to asbestos are its clearance, removal and disposal.

The IARC (International Agency for Research on Cancer) has classified asbestos as a human carcinogen (Group 1).

The danger of asbestos derives from the degree of fibre freedom, i.e. the ability of asbestos-containing materials to release potentially inhalable fibres into the air. Since asbestos is a friable and fibrous material, it is easy for very small particles to be released into the air as a result of any type of stress (processing and handling, vibrations, infiltration of humidity), which, once inhaled, are capable of being deposited in the pulmonary alveoli, bronchi and pleura, causing irreversible tissue damage and the onset of pulmonary diseases. Moreover, as there is no risk threshold below which the concentration of asbestos fibres in the air is not dangerous, it follows that the inhalation of even a single fibre can cause fatal pathologies; clearly, prolonged exposure over time or to high quantities will exponentially increase the likelihood of contracting such pathologies.

The European Commission has recently approved an exposure limit value (or TLV) 10 times lower than the previous one (0.1 fibres/cm3), i.e. 0.01 fibres/cm3, for an 8-hour exposure reference. The harmful effects that occur following the inhalation of asbestos particles are derived from pathogenic mechanisms of an irritative, degenerative and carcinogenic nature and can lead to the onset of various diseases.

The pathologies resulting from breathing in asbestos fibres are all characterised by a long interval between the start of exposure and the appearance of the first symptoms of the disease: this interval, termed 'latency time', can generally last up to decades.

From these pathologies related to exposure to asbestos derives the importance of worker protection, which must be on several fronts: the worker must be equipped with personal respiratory protective equipment with an operational protection factor that ensures that the filtered air inside the PPE is no more than 1/10 of the limit value. The use of PPE must also be interspersed with rest periods appropriate to the physical effort required by the work, and the employer must carry out periodic measurements of the concentration of fibres in the air, reporting the results in the DVR (Risk Assessment Document).

 

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Gerelateerde artikelen

december 22, 2021 BLS vi augura buone feste

Il 2021 è stato l'anno in cui insieme abbiamo ottenuto risultati incredibili. Noi di BLS vogliamo ricordarlo così. Senza di voi tutto questo non sarebbe mai stato possibile. Nonostante le fatiche di quest'anno, il 2021 si è anche rivelato ricco di soddisfazioni. Grazie di cuore per essere stati al nostro fianco e per aver creduto […]

Link
maart 8, 2021 "Everyone has the right to a safe job” adv campaign

“Tutti hanno diritto ad un lavoro sicuro”: questo il messaggio della nostra nuova campagna pubblicitaria. Duplice l'obiettivo: sensibilizzare da una parte sull’importanza di un posto di lavoro stabile, soprattutto in un momento storico caratterizzato dall’incertezza causata dall’emergenza sanitaria, dall’altra sulla sicurezza e la protezione del singolo sul luogo di lavoro, principio cardine dell’azienda.   Ideata […]

Link
oktober 8, 2019 Preventica Exhibition 2019 - Marseille, France

BLS team is pleased to invite you toPREVENTICA MARSEILLE Parc Chanot, October 8th-10th, 2019The event on health and safety at workVisit us in booth E34.Get your ticket! Register as a visitor to the show and print your professional accreditation. This will give you access to the lounge, according to the established conditions.Register

Link

Abonneer op onze nieuwsbrief

Ontvang updates over onze evenementen, nieuws, catalogus en aankomende initiatieven.
Abonneren

Neem contact op

Laat uw bericht achter, wij antwoorden binnen 48 uur.
Vraag informatie aan

BLS S.R.L.
Società a Socio Unico
via dei Giovi, 41 - 20032 Cormano (MI) - Italia
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Privacy Policy - Cookie Policy

Geregistreerd kantoor
via dei Giovi, 41 – 20032 Cormano (MI) - Italia
Capitale Sociale | Share Capital: Euro 600.000,00 i.v.
C.C.I.A.A. - R.E.A.: MI 1186898
Partita IVA | VAT N°: IT12296780153
C.F. e Iscrizione al Registro delle Imprese di Milano: 07822320151

BLS IBERIA / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Spain
BLS NORTHWEST / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - The Netherlands
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 Sao Paulo - SP - Brazil
BLS GERMANY / Steindeich 1a, 25377 Kollmar - Germany
BLS FRANCE / 18 Porte du Grand Lyon 01700 Neyron - France

crossmenuchevron-downcross-circle
NL